Edition:
United States

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

195.17USD
4:02pm EDT
Change (% chg)

$0.73 (+0.38%)
Prev Close
$194.44
Open
$194.73
Day's High
$195.40
Day's Low
$193.42
Volume
200,460
Avg. Vol
393,464
52-wk High
$198.74
52-wk Low
$144.77

About

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $55,735.43
Shares Outstanding(Mil.): 374.06
Dividend: 0.43
Yield (%): 1.14

Financials

  SYK.N Industry Sector
P/E (TTM): 33.24 32.18 32.54
EPS (TTM): 4.48 -- --
ROI: 9.81 13.74 13.82
ROE: 17.77 16.44 15.24

Appeals court upholds $254 million patent verdict for Stryker against Zimmer

A federal appeals court on Monday upheld a $254 million patent infringement verdict Stryker Corp won against rival medical device maker Zimmer Biomet Holdings Inc, bringing a likely end to a long-running court battle that previously ended up before the U.S. Supreme Court.

Dec 14 2018

7th Circuit revives claim that Stryker fired worker over harassment complaint

A federal appeals court on Monday revived a retaliation lawsuit against medical device maker Stryker Corp by a former employee who says she was fired for reporting that a sales manager had sexually harassed a coworker.

Oct 15 2018

Stryker to pay $7.8 million to settle Foreign Corrupt Practices Act charges

WASHINGTON Medical device company Stryker Corp. will pay $7.8 million to settle charges it violated the Foreign Corrupt Practices Act, without admitting or denying the allegations, the top U.S. securities regulator said on Friday.

Sep 28 2018

Stryker to pay $7.8 mln to settle Foreign Corrupt Practices Act charges

WASHINGTON, Sept 28 Medical device company Stryker Corp. will pay $7.8 million to settle charges it violated the Foreign Corrupt Practices Act, without admitting or denying the allegations, the top U.S. securities regulator said on Friday.

Sep 28 2018

Earnings vs. Estimates